Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $296.57, ...

Derivatives marketplace CME Group (NASDAQ:CME) was downgraded at UBS over a recent slowdown in activity after a strong ...

KBW analyst Kyle Voigt maintained a Hold rating on CME Group today and set a price target of $283.00. The company’s shares closed yesterday at $276.48. Elevate Your Investing St ...

Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018.

Oppenheimer analyst Owen Lau maintained a Buy rating on CME Group today and set a price target of $303.00. The company’s shares closed yesterday at $276.48. Elevate Your Investi ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Summary. CME Group gets rated buy again, reaffirming my last rating. The firm is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key ...

CME Group's strong performance and market-agnostic revenues support its resilience, but the recent 40%+ share price surge stretches its valuation. While the Company's dividend yield is attractive ...

Dennis Suskind, Board Member at CME Group (NASDAQ:CME), reported an insider buy on June 26, according to a new SEC filing. What Happened: ... View More Analyst Ratings for CME.